Masked Arginine Vasopressin Deficiency in a Kidney Transplant Recipient With Posttransplant Lymphoproliferative Disorder

Masked Arginine Vasopressin Deficiency in a Kidney Transplant Recipient With Posttransplant Lymphoproliferative Disorder

Saved in:

Bibliographic Details
Main Authors:	Annie Liu, Lakshmi Nayak, Waihay J. Wong, Inhye E. Ahn, Naoka Murakami
Format:	Article
Language:	English
Published:	Elsevier 2024-09-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924018060
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Impact of Posttransplant Lymphoproliferative Disease in High-risk Kidney Transplant Recipients: Benefits of Prevention
by: Bryce A. Kiberd, MD, et al.
Published: (2025-05-01)

Posttransplant Lymphoproliferative Disease after Lung Transplantation
by: Isabel P. Neuringer
Published: (2013-01-01)

Posttransplant Lymphoproliferative Disorders
by: Hazem A. H. Ibrahim, et al.
Published: (2012-01-01)

Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation
by: Martin Mynarek, et al.
Published: (2013-01-01)

Posttransplant Lymphoproliferative Disorder Presenting as Testicular Lymphoma in a Kidney Transplant Recipient: A Case Report and Review of the Literature
by: Steve Omoruyi Obanor, et al.
Published: (2018-01-01)

Delayed onset arginine vasopressin deficiency after traumatic brain injury
by: Silviu-Andrei Tomulescu, et al.
Published: (2024-10-01)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant
by: Bharat Malhotra, et al.
Published: (2015-01-01)

Autoimmune Phenomenon Associated With Posttransplant Lymphoproliferative Disorder
by: Pierre Isnard, et al.
Published: (2024-03-01)

Feasibility and Safety of Ex Vivo Delivery of Rituximab to Lung Allografts in Transplant Recipients at High Risk for Epstein-Barr Virus–associated Posttransplant Lymphoproliferative Disorder
by: Victor H. Ferreira, PhD, et al.
Published: (2025-04-01)

Castleman’s Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-Up
by: Lokesh K. Jha, et al.
Published: (2018-01-01)

Isolated Upper Extremity Posttransplant Lymphoproliferative Disorder in a Child
by: Sarah E. Halula, et al.
Published: (2015-01-01)

Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders
by: Vikas R. Dharnidharka, et al.
Published: (2019-03-01)

Hydrocortisone and arginine vasopressin in post-resuscitation shock: the HYVAPRESS trial
by: Guillaume Geri, et al.
Published: (2025-07-01)

Arginine vasopressin and copeptin: comparative review and perspective in veterinary medicine
by: Mathieu Victor Paulin, et al.
Published: (2025-03-01)

Ophthalmoplegia and Tumor Lysis Syndrome: An Uncommon Presentation of Posttransplant Lymphoproliferative Disorder
by: Lauren M. Granat, et al.
Published: (2022-09-01)

Hypothalamic–pituitary–adrenal dynamics in early-stage COVID-19 observed in a case with arginine vasopressin deficiency
by: Hinako Kirikae, et al.
Published: (2025-07-01)

Effect of arginine vasopressin on breathing movements of chronically instrumented fetal lambs
by: Takefumi Bessho, et al.
Published: (1997-02-01)

Modulation of empathic abilities by the interplay between estrogen receptors and arginine vasopressin
by: Rui Du, et al.
Published: (2025-01-01)

Predictive modeling of arginine vasopressin deficiency after transsphenoidal pituitary adenoma resection by using multiple machine learning algorithms
by: Yuyang Chen, et al.
Published: (2024-09-01)

Late-Onset Posttransplant Lymphoproliferative Disorders after Solid Organ Transplantation in Adults: A Case Series and Review of the Literature
by: S. Gandhi, et al.
Published: (2020-01-01)

Assessing Risk Factors and Posttransplant Outcomes of Nonadherence Among Kidney Transplant Recipients
by: Kateryna Maksyutynska, HBSc, et al.
Published: (2025-06-01)

Arginine Vasopressin-Independent Mechanism of Impaired Water Excretion in a Patient with Sarcoidosis Complicated by Central Diabetes Insipidus and Glucocorticoid Deficiency
by: Katsunobu Yoshioka, et al.
Published: (2011-01-01)

Serum Sodium Concentration During Arginine Vasopressin Infusion in Critically Ill Children
by: Rafael Muff, et al.
Published: (2024-11-01)

The Impact of Hydration on Metabolic Outcomes: From Arginine-Vasopressin Signaling to Clinical Implications
by: Andrijana Koceva, et al.
Published: (2025-05-01)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
by: Clare J. Twist, et al.
Published: (2013-01-01)

Post-transplant lymphoproliferative disorder in adult renal transplant recipients: case series and review of literature
by: Dorota Kamińska, et al.
Published: (2021-01-01)

Arginine Vasopressin Injected into the Dorsal Motor Nucleus of the Vagus Inhibits Gastric Motility in Rats
by: Jianping Zhu, et al.
Published: (2016-01-01)

Silence before the Storm – Mycotic Aneurysm in Posttransplant Recipient
by: G. Praveen, et al.
Published: (2025-01-01)

Characteristics of Post-Transplant Lymphoproliferative Disorder in Adult Liver Transplant Recipients—A Single Centre Experience
by: Katrina Tan, et al.
Published: (2025-06-01)

Molecular Pathogenesis of B-Cell Posttransplant Lymphoproliferative Disorder: What Do We Know So Far?
by: J. Morscio, et al.
Published: (2013-01-01)

Physiological basis of arginine vasopressin deficiency (AVP-D, formerly central diabetes insipidus) and AVP-resistance (AVP-R, formerly nephrogenic diabetes insipidus)
by: Osah Martins Onwuka
Published: (2025-02-01)

Deficiency of arginine vasopressin in children – diagnostic and therapeutic approaches to improve patients' quality of life based on a 25-year, single-centre retrospective analysis
by: Dorota Roztoczyńska, et al.
Published: (2025-01-01)

Posttransplant Hyponatremia Predicts Graft Failure and Mortality in Kidney Transplantation Recipients: A Multicenter Cohort Study in Korea.
by: Seung Seok Han, et al.
Published: (2016-01-01)

Primary central nervous system post-transplant lymphoproliferative Disorder in a lung transplant recipient despite reduction of immunosuppression
by: K Afshar, et al.
Published: (2025-02-01)

Patterns of belatacept use and risk of post-transplant lymphoproliferative disorder in US kidney transplant recipients: An analysis of the Organ Procurement and Transplantation Network database.
by: Wida S Cherikh, et al.
Published: (2025-01-01)

Hemodynamic effects of adjunct arginine vasopressin to norepinephrine in septic shock: insights from a prospective multicenter registry study
by: Max Melchers, et al.
Published: (2025-04-01)

DYNAMIC RENAL SCINTIGRAPHY POTENTIAL TO DIAGNOSE RENAL POSTTRANSPLANT COMPLICATIONS IN KIDNEY RECIPIENTS
by: A.V. Kapishnikov, et al.
Published: (2014-05-01)

Secondary Subcutaneous Rhizopus Infection in a Posttransplant Recipient with Calcific Uremic Arteriolopathy
by: Urmila Anandh, et al.
Published: (2020-01-01)

Management of Diffuse Large B-Cell Lymphoma as Post-Transplant Lymphoproliferative Disorder in a Kidney Transplant Recipient: A Case Report
by: Salem Alshemmari, et al.
Published: (2025-04-01)

Central nervous system posttransplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation successfully treated with combination therapy of acalabrutinib and immunochemotherapy: A case report and literature review
by: Peihao Zheng, et al.
Published: (2025-02-01)